STRATA Skin Financials
SSKN Stock | USD 2.68 0.02 0.75% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.39 | 1.47 |
|
|
The essential information of the day-to-day investment outlook for STRATA Skin includes many different criteria found on its balance sheet. An individual investor should monitor STRATA Skin's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in STRATA Skin.
Net Income |
|
STRATA | Select Account or Indicator |
STRATA Skin Sciences Earnings Geography
STRATA Skin Stock Summary
STRATA Skin competes with Axogen, Ainos, LENSAR, Nexalin Technology, and Ainos. STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Strata Skin operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US86272A2069 |
CUSIP | 86272A206 55277R100 55277R308 86272A107 86272A305 285192100 |
Location | Pennsylvania; U.S.A |
Business Address | 5 Walnut Grove |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.strataskinsciences.com |
Phone | 215 619 3200 |
Currency | USD - US Dollar |
STRATA Skin Key Financial Ratios
Return On Equity | -0.73 | ||||
Profit Margin | (0.29) % | ||||
Operating Margin | (0.19) % | ||||
Price To Sales | 0.35 X | ||||
Revenue | 33.36 M |
STRATA Skin Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 46.8M | 46.6M | 52.3M | 42.0M | 48.3M | 30.1M | |
Retained Earnings | (219.0M) | (221.7M) | (227.2M) | (238.1M) | (214.3M) | (203.5M) | |
Total Current Assets | 24.8M | 20.0M | 17.5M | 15.5M | 17.9M | 17.2M | |
Other Current Assets | 7.8M | 924K | 2.7M | 1.6M | 1.9M | 1.1M | |
Total Liab | 20.9M | 21.2M | 30.4M | 29.3M | 33.7M | 35.4M | |
Other Current Liab | 1.6M | 2.4M | 2.5M | 2.0M | 2.3M | 1.4M | |
Net Debt | 278K | (4.6M) | 3.0M | 8.8M | 10.2M | 10.7M | |
Cash | 10.6M | 12.6M | 5.4M | 6.8M | 6.1M | 10.1M | |
Accounts Payable | 2.8M | 2.8M | 3.4M | 3.3M | 3.8M | 2.5M | |
Other Assets | 428K | 347K | 1.3M | 216K | 248.4K | 301.5K | |
Net Receivables | 2.9M | 3.4M | 4.5M | 4.4M | 5.1M | 2.6M | |
Inventory | 3.4M | 3.5M | 5.5M | 2.7M | 3.1M | 3.3M | |
Short Term Debt | 9.1M | 636K | 710K | 352K | 316.8K | 301.0K | |
Intangible Assets | 6.3M | 10.1M | 17.4M | 7.3M | 8.4M | 5.6M | |
Other Liab | 499K | 178K | 288K | 666K | 765.9K | 1.1M | |
Net Tangible Assets | 12.7M | 11.9M | 10.7M | 6.5M | 5.9M | 6.7M |
STRATA Skin Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Revenue | 23.1M | 30.0M | 36.2M | 33.4M | 38.4M | 19.5M | |
Gross Profit | 14.1M | 19.9M | 21.8M | 18.5M | 21.2M | 11.1M | |
Operating Income | (4.1M) | (4.4M) | (4.6M) | (8.6M) | (7.7M) | (8.1M) | |
Ebit | (4.1M) | (2.4M) | (4.6M) | (9.3M) | (8.4M) | (8.8M) | |
Research Development | 1.3M | 1.4M | 1.0M | 1.3M | 1.2M | 1.1M | |
Ebitda | (165.0K) | 1.7M | 1.1M | (3.4M) | (3.9M) | (4.1M) | |
Cost Of Revenue | 9.0M | 10.1M | 14.4M | 14.9M | 17.1M | 10.5M | |
Net Income | (4.4M) | (2.7M) | (5.5M) | (10.8M) | (9.7M) | (10.2M) | |
Income Tax Expense | 275K | 34K | 63K | (92K) | (105.8K) | (111.1K) | |
Interest Expense | 211K | 314K | 926K | 1.6M | 1.9M | 1.3M | |
Income Before Tax | (4.1M) | (2.7M) | (5.5M) | (10.9M) | (12.6M) | (13.2M) | |
Tax Provision | 275K | 34K | 63K | (92K) | (82.8K) | (78.7K) | |
Interest Income | 150K | 15K | 89K | 192K | 172.8K | 164.2K | |
Net Interest Income | (61K) | (299K) | (837K) | (1.2M) | (1.4M) | (1.4M) |
STRATA Skin Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 2.5M | (5.5M) | (5.8M) | 1.3M | 1.2M | 814.7K | |
Free Cash Flow | (63K) | (2.1M) | (4.7M) | (5.5M) | (6.4M) | (6.7M) | |
Depreciation | 3.9M | 4.1M | 5.7M | 5.9M | 6.8M | 7.1M | |
Other Non Cash Items | 114K | (1.9M) | 316K | 3.3M | 3.8M | 2.2M | |
Capital Expenditures | 2.2M | 3.7M | 3.6M | 5.0M | 5.8M | 6.1M | |
Net Income | (4.4M) | (2.7M) | (5.5M) | (10.8M) | (12.5M) | (13.1M) | |
End Period Cash Flow | 18.1M | 12.6M | 6.8M | 8.1M | 7.3M | 10.5M | |
Change To Inventory | (417K) | (45K) | (1.5M) | 689K | 620.1K | 651.1K | |
Change To Netincome | 978K | 1.1M | 2.0M | (233K) | (209.7K) | (199.2K) | |
Net Borrowings | (3.4M) | (296K) | 2.5M | 225K | 202.5K | 192.4K | |
Investments | (2.2M) | (7.1M) | (4.2M) | (4.7M) | (4.2M) | (4.4M) |
STRATA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining STRATA Skin's current stock value. Our valuation model uses many indicators to compare STRATA Skin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STRATA Skin competition to find correlations between indicators driving STRATA Skin's intrinsic value. More Info.STRATA Skin Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, STRATA Skin's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STRATA Skin's earnings, one of the primary drivers of an investment's value.STRATA Skin's Earnings Breakdown by Geography
STRATA Skin Sciences Systematic Risk
STRATA Skin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STRATA Skin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on STRATA Skin Sciences correlated with the market. If Beta is less than 0 STRATA Skin generally moves in the opposite direction as compared to the market. If STRATA Skin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STRATA Skin Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STRATA Skin is generally in the same direction as the market. If Beta > 1 STRATA Skin moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in STRATA Skin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various STRATA Skin's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of STRATA Skin growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
STRATA Skin March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of STRATA Skin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STRATA Skin Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of STRATA Skin Sciences based on widely used predictive technical indicators. In general, we focus on analyzing STRATA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STRATA Skin's daily price indicators and compare them against related drivers.
Information Ratio | (0.02) | |||
Maximum Drawdown | 17.04 | |||
Value At Risk | (5.40) | |||
Potential Upside | 5.15 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.53) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.